Firstranker's choice
FINAL EXAM
JUNE 2019
Time: 3 hours
--- Content provided by FirstRanker.com ---
MEDICAL ONCOLOGY
PAPER-III
Max. Marks:100
Important Instructions:
- Attempt all questions in order.
- Each question carries 10 marks.
- Read the question carefully and answer to the point neatly and legibly.
- Do not leave any blank pages between two answers.
- Indicate the question number correctly for the answer in the margin space.
- Answer all the parts of a single question together.
- Start the answer to a question on a fresh page or leave adequate space between two answers.
- Draw table/diagrams/flowcharts wherever appropriate.
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
Write short notes on:
- a) Staging of neuroblastoma. (3)
b) Paraneoplastic syndromes associated with neuroblastoma. (3)
c) Management of stage IV neuroblastoma. (4) - a) Treatment of low risk gestational trophoblastic neoplasm. (4)
--- Content provided by FirstRanker.com ---
b) Mixed Mullerian tumour (carcinosarcoma) of uterus. (3)
c) Sertoli-Leydig cell tumour of ovary. (3) - a) How will you evaluate a solitary, large supratentorial brain SOL in a 60-year-old male presenting with neuro-cognitive decline? (5)
b) Management of newly diagnosed primary CNS lymphoma. (5) - a) Role of autologous PBSCT in Non-Hodgkin's Lymphoma (NHL). (3)
--- Content provided by FirstRanker.com ---
b) Conditioning regimes for autologous PBSCT in NHL. (3)
c) Acute GVHD (Graft vs Host disease) (4) - a) Indications of treatment in chronic lymphocytic leukemia (CLL). (3)
b) Treatment options in newly diagnosed CLL. (3)
c) Management of hairy cell leukemia. (4) - a) How do you approach abdominal mass on 5-year-old child? (4)
b) Staging of Wilms’ tumour. (3)
c) Management of bilateral Wilms’ tumour. (3) - a) WHO classification of Myelodysplastic syndrome (MDS). (4)
b) Prognostic scoring systems in MDS. (3)--- Content provided by FirstRanker.com ---
c) 5q deletion syndrome. (3) - a) Diagnostic criteria for Waldenstrom Macroglobulinemia (WM). (3)
b) International Prognostic scoring staging system in WM. (3)
c) Treatment of newly diagnosed WM. (4) - a) Management of Ph positive ALL. (4)
--- Content provided by FirstRanker.com ---
b) Role of MRD in ALL treatment. (3)
c) Phlike ALL and its management. (3) - a) Systemic therapy for medullary thyroid cancer. (4)
b) Management of radioiodine refractory papillary thyroid carcinoma. (3)
c) Anaplastic thyroid carcinoma. (3)
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
--- Content provided by FirstRanker.com ---
This download link is referred from the post: DNB 2019 June Previous Question Papers-(Diplomate of National Board) Under NBE